Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China · Delayed Price · Currency is CNY 7.14
-0.17 (-2.33%)
Feb 4, 2026, 3:08 PM CST
SHE:300639 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -520.64 | -654.88 | 140.47 | 1,726 | 852.16 | 362.66 |
Depreciation & Amortization | 166.79 | 166.79 | 178.43 | 178.89 | 87.3 | 50.04 |
Other Amortization | 31.6 | 31.6 | 13.9 | 14.2 | 16.68 | 13.85 |
Loss (Gain) From Sale of Assets | 0.25 | 0.25 | -7.06 | -4.34 | -2.34 | -5.06 |
Asset Writedown & Restructuring Costs | 24.79 | 24.79 | -1.56 | 291.75 | 6.34 | 0.93 |
Loss (Gain) From Sale of Investments | -9.2 | -9.2 | -13.94 | -21.35 | -20.6 | -5.33 |
Provision & Write-off of Bad Debts | 606.96 | 606.96 | -10.76 | 250.48 | - | - |
Other Operating Activities | -336.97 | -279.55 | -54.85 | 176.49 | 40.18 | 32.8 |
Change in Accounts Receivable | 161.22 | 161.22 | 873.52 | -1,920 | -648.08 | -275.72 |
Change in Inventory | 18.16 | 18.16 | 52.38 | -63.36 | -51.15 | -53.21 |
Change in Accounts Payable | -113.45 | -113.45 | -802.73 | 698.97 | 289.93 | 156.22 |
Change in Other Net Operating Assets | 11.59 | 11.59 | 11.44 | 61.48 | -17.77 | 4.88 |
Operating Cash Flow | 155.6 | 78.78 | 319.6 | 1,309 | 631.34 | 311.3 |
Operating Cash Flow Growth | -10.49% | -75.35% | -75.59% | 107.37% | 102.81% | 175.90% |
Capital Expenditures | -66.31 | -148.33 | -385.32 | -734.37 | -641.07 | -287.12 |
Sale of Property, Plant & Equipment | 0.9 | 0.4 | 17.74 | 13.72 | 6.34 | 6.92 |
Investment in Securities | -230.92 | 37.58 | 74.73 | 115.89 | 131.39 | -909.67 |
Other Investing Activities | -1.43 | - | 7.64 | - | - | - |
Investing Cash Flow | -303.45 | -110.35 | -285.21 | -604.75 | -503.35 | -1,190 |
Short-Term Debt Issued | - | - | - | - | 248.33 | 81.27 |
Long-Term Debt Issued | - | 55.32 | 79.86 | 200.79 | - | - |
Total Debt Issued | 46 | 55.32 | 79.86 | 200.79 | 248.33 | 81.27 |
Short-Term Debt Repaid | - | - | - | - | -172.27 | -6 |
Long-Term Debt Repaid | - | -21.01 | -163.82 | -265.91 | -8.25 | -0.08 |
Total Debt Repaid | -32.43 | -21.01 | -163.82 | -265.91 | -180.52 | -6.08 |
Net Debt Issued (Repaid) | 13.57 | 34.3 | -83.97 | -65.12 | 67.81 | 75.19 |
Issuance of Common Stock | 8 | - | - | 10 | 70.25 | 1,037 |
Repurchase of Common Stock | -65.11 | -65.11 | -50 | -50 | -49.97 | -50.18 |
Common Dividends Paid | -2.37 | -44.46 | -160.46 | -114.29 | -76.09 | -43.76 |
Other Financing Activities | -39.95 | -0 | 0.02 | -0 | -3.5 | -2.05 |
Financing Cash Flow | -85.86 | -75.27 | -294.4 | -219.41 | 8.5 | 1,017 |
Foreign Exchange Rate Adjustments | 12.59 | 7.59 | 0.95 | 13.4 | -5.48 | -4.37 |
Net Cash Flow | -221.12 | -99.25 | -259.07 | 498.46 | 131.01 | 133.63 |
Free Cash Flow | 89.29 | -69.55 | -65.72 | 574.85 | -9.73 | 24.18 |
Free Cash Flow Margin | 12.92% | -8.53% | -5.95% | 10.27% | -0.36% | 1.79% |
Free Cash Flow Per Share | 0.14 | -0.11 | -0.12 | 0.87 | -0.01 | 0.04 |
Cash Income Tax Paid | 39.19 | 117.22 | 364.68 | 311.22 | 171.2 | 94.69 |
Levered Free Cash Flow | 372.89 | 300.75 | -75.69 | 74.02 | -231.66 | -129.29 |
Unlevered Free Cash Flow | 374.8 | 301.73 | -72.6 | 79.14 | -227.03 | -128.79 |
Change in Working Capital | 192.02 | 192.02 | 74.97 | -1,303 | -400.44 | -158.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.